05/02/2025
4:09 PM | Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
Rodgers Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2025
3:08 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form DEFA14A | |
04/11/2025
3:36 PM | Opus Genetics, Inc. (Subject)
Opus Genetics, Inc. (Subject)
Opus Genetics (Subject)
Sooch Mina (Filed by)
| Form PX14A6G | |
04/10/2025
11:15 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form EFFECT | |
04/10/2025
4:04 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form DEFA14A | |
04/09/2025
4:00 PM | Opus Genetics, Inc. (Subject)
Opus Genetics, Inc. (Subject)
Opus Genetics (Subject)
Sooch Mina (Filed by)
| Form DFAN14A | |
04/08/2025
5:54 AM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form S-3/A | |
04/07/2025
8:13 AM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form DEFA14A | |
04/04/2025
3:39 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2025
3:23 PM | Opus Genetics, Inc. (Subject)
Opus Genetics, Inc. (Subject)
Opus Genetics (Subject)
Sooch Mina (Filed by)
| Form PRRN14A | |
04/04/2025
3:25 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form 424B5 | |
Get the Latest News and Ratings for IRD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Opus Genetics and its competitors with MarketBeat's FREE daily newsletter. |
04/02/2025
4:23 PM | Opus Genetics, Inc. (Subject)
Opus Genetics, Inc. (Subject)
Opus Genetics (Subject)
| Form DEFC14A | |
04/02/2025
3:30 PM | Opus Genetics, Inc. (Subject)
Opus Genetics, Inc. (Subject)
Opus Genetics (Subject)
Sooch Mina (Filed by)
| Form DFAN14A | |
03/31/2025
4:14 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/31/2025
8:16 AM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form PRER14A | |
03/31/2025
7:26 AM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
3:31 PM | Opus Genetics, Inc. (Subject)
Opus Genetics, Inc. (Subject)
Opus Genetics (Subject)
Sooch Mina (Filed by)
| Form DFAN14A | |
03/24/2025
4:27 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
6:14 AM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form 424B5 | |
03/21/2025
4:26 PM | Opus Genetics, Inc. (Subject)
Opus Genetics, Inc. (Subject)
Opus Genetics (Subject)
Sooch Mina (Filed by)
| Form DFAN14A | |
03/21/2025
3:33 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form PRER14A | |
03/21/2025
11:55 AM | Opus Genetics, Inc. (Subject)
Opus Genetics, Inc. (Subject)
Opus Genetics (Subject)
Sooch Mina (Filed by)
| Form PREC14A | |
03/21/2025
7:25 AM | Opus Genetics, Inc. (Subject)
Opus Genetics, Inc. (Subject)
Opus Genetics (Subject)
| Form FWP | |
03/20/2025
4:27 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2025
4:23 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form 424B5 | |
03/20/2025
4:24 PM | Opus Genetics, Inc. (Subject)
Opus Genetics, Inc. (Subject)
Opus Genetics (Subject)
| Form FWP | |
03/20/2025
3:10 PM | Opus Genetics, Inc. (Subject)
Opus Genetics, Inc. (Subject)
Opus Genetics (Subject)
| Form PREC14A | |
03/20/2025
8:21 AM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
7:56 PM | Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
SCHACHLE JOSEPH K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
7:49 PM | Hoffmann Bernhard (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
7:50 PM | Jayagopal Ashwath (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
7:52 PM | Jhaveri Nirav S. (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
7:53 PM | Magrath George (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
7:54 PM | Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
Zaremba Rabourn Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
10:41 AM | Opus Genetics, Inc. (Subject)
Opus Genetics, Inc. (Subject)
Opus Genetics (Subject)
Sooch Mina (Filed by)
| Form DFAN14A | |
02/06/2025
3:37 PM | Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
Zaremba Rabourn Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:35 PM | Hoffmann Bernhard (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:34 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2025
4:20 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
8:10 AM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
4:29 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form 424B5 | |
Elon Set to Shock the World by May 1st ? (Ad) Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever…
Yes, even bigger than Tesla or SpaceX. Click here now because after June 1st, it could be too late. |
01/07/2025
4:10 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K/A | |
01/06/2025
3:42 PM | Bennett Jean (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:43 PM | MANUSO JAMES S J (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:26 PM | Magrath George (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
4:50 PM | Magrath George (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:18 PM | Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
YERXA BENJAMIN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
5:08 AM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/05/2024
3:13 PM | Magrath George (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
4:07 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/29/2024
4:26 PM | Foundation Fighting Blindness Retinal Degeneration Fund (Filed by)
Opus Genetics, Inc. (Subject)
Opus Genetics, Inc. (Subject)
Opus Genetics (Subject)
| Form SC 13D | |
10/29/2024
4:10 PM | Foundation Fighting Blindness Retinal Degeneration Fund (Reporting)
Foundation Fighting Blindness, Inc. (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/24/2024
4:54 PM | Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
YERXA BENJAMIN R (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/24/2024
4:56 PM | Bennett Jean (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2024
4:59 PM | Graves Adrienne L (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2024
4:49 PM | Bennett Jean (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/24/2024
4:52 PM | Graves Adrienne L (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
4:09 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
7:14 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
4:30 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
Pepose Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:31 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
Rodgers Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:23 PM | Ainsworth Sean (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:25 PM | Benton Susan (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:27 PM | Gallagher Cam (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:28 PM | MANUSO JAMES S J (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:06 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
3:07 PM | Jayagopal Ashwath (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:18 PM | Magrath George (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
3:35 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
7:12 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
